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Medicine, University of Illinois at Chicago, Chicago, IllinoisABSTRACT During b-adrenergic stimulation, cardiac troponin I (cTnI) is phosphorylated by protein kinase A (PKA) at sites
S23/S24, located at the N-terminus of cTnI. This phosphorylation has been shown to decrease KCa and pCa50, and weaken
the cTnC-cTnI (C-I) interaction. We recently reported that phosphorylation results in an increase in the rate of early, slow
phase of relaxation (kREL,slow) and a decrease in its duration (tREL,slow), which speeds up the overall relaxation. However, as
the N-terminus of cTnI (residues 1–40) has not been resolved in the whole cardiac troponin (cTn) structure, little is known about
the molecular-level behavior within the whole cTn complex upon phosphorylation of the S23/S24 residues of cTnI that results in
these changes in function. In this study, we built up the cTn complex structure (including residues cTnC 1–161, cTnI 1–172, and
cTnT 236–285) with the N-terminus of cTnI. We performed molecular-dynamics (MD) simulations to elucidate the structural
basis of PKA phosphorylation-induced changes in cTn structure and Ca2þ binding. We found that introducing two phosphomimic
mutations into sites S23/S24 had no significant effect on the coordinating residues of Ca2þ binding site II. However, the overall
fluctuation of cTn was increased and the C-I interaction was altered relative to the wild-type model. The most significant changes
involved interactions with the N-terminus of cTnI. Interestingly, the phosphomimic mutations led to the formation of intrasubunit
interactions between the N-terminus and the inhibitory peptide of cTnI. This may result in altered interactions with cTnC and
could explain the increased rate and decreased duration of slow-phase relaxation seen in myofibrils.INTRODUCTIONTroponin (Tn) and tropomyosin (Tm) regulate thin-filament
interactions with the thick filament in a Ca2þ-dependent
manner (1,2). Cardiac Tn (cTn) serves as a critical regulator
of contraction in cardiac muscle and consists of three
distinct subunits (cTnC, cTnI, and cTnT), each named ac-
cording to their function (3). Contractile activation of car-
diac muscle is initiated by Ca2þ binding to the regulatory
domain of cTnC (site II). The resulting conformational
change triggers the movement of the switch peptide of the
inhibitory subunit cTnI (residues 147–163) toward hydro-
phobic residues exposed within the N-terminal portion of
cTnC (NcTnC). The movement of the cTnI switch peptide
pulls the adjacent inhibitory peptide (residues 137–146)
away from the actin-Tm complex. Consequently, the
mobility of Tm on the thin filament is increased, resulting
in increased exposure of myosin-binding sites on actin.
b-Adrenergic stimulation is a primary physiological
mechanism for meeting increased circulatory demands via
positive inotropic and lusitropic effects (4). During b-adren-
ergic stimulation, cTnI is phosphorylated by protein kinase
A (PKA) at sites S23/S24, which are located within the car-Submitted March 25, 2014, and accepted for publication August 11, 2014.
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cTnI (C-I) interaction is critical for contractile modulation
of beat-to-beat systolic needs and during adrenergic stimu-
lation (6). When cTnI is phosphorylated, the C-I interaction
is weakened (4,7), leading to a reduction in the Ca2þ affinity
of the regulatory domain of cTnC and the Ca2þ sensitivity of
force generation, as well as an increase in the rates of mus-
cle relaxation (4,5,8).
Little is known about the molecular-level structural
changes that occur in the whole Tn complex upon phosphor-
ylation of the S23/S24 residues of cTnI and result in these
changes in function. NMR and x-ray crystallography have
shed light on the atomic-level structures of the cTnC regu-
latory domain and the cTn complex (9–11). Spyracopoulos
et al. (9) and Li et al. (10) solved NMR structures of the reg-
ulatory domain of cTnC in both Ca2þ-saturated and Ca2þ-
free states, as well as the regulatory domain of cTnC in
complex with the switch peptide of cTnI. Based on these
NMR structures, Lindert et al. (12) and Kekenes-Huskey
et al. (13) studied the dynamics of NcTnC, as well as
Ca2þ association with NcTnC, via both conventional and
accelerated molecular dynamics (MD) simulations, and
examined the exposure dynamics and kinetics of cTnC hy-
drophobic residues via microsecond MD simulations (14).
Wang et al. (15,16) applied experimental and computationalhttp://dx.doi.org/10.1016/j.bpj.2014.08.008
1676 Cheng et al.approaches to study the interactions of cTnC variants with
altered Ca2þ-binding affinities with the switch peptide of
cTnI. In 2003, Takeda et al. (11) published the first crystal
structure of the human cTn complex in the Ca2þ-saturated
form. Varughese et al. (17) used this structure to study the
binding of the drug Bepridil to cTnC, design a set of poten-
tial cTnC-binding ligands (18), and study the interactions
and correlated motions among the three components of
cTn (19). Using fluorescence resonance energy transfer
techniques in combination with MD simulations, Jayasun-
dar et al. (20) studied the molecular details of how a Ca2þ
signal received at cTnC is transmitted to cTnI. All of these
studies used either partial models of cTnC with the cTnI
switch peptide or the Tn model without the N-terminus of
cTnI. Thus, the basis of how PKA phosphorylation influ-
ences cTn structure and Ca2þ binding remains elusive.
Recently, Howarth et al. (21) used solution NMR to deter-
mine the structure of the N-terminal extension of cTnI for
both nonphosphorylated and bis-phosphorylated species,
thereby making computational models to study PKA-medi-
ated phosphorylation feasible. They then combined the
N-terminal NMR structure with the crystal structure of
core cTn to create an atomic model of cTn consistent with
the spectroscopic data.
A computational investigation of how cTnI phosphoryla-
tion influences C-I interactions and Ca2þ binding to cTnC is
an important step toward understanding the molecular basis
of myofilament function during b-adrenergic stimulation. In
this study, we built up the structure of the cTn complex
(including residues cTnC 1–161, cTnI 1–172, and cTnT
236–285) containing the cardiac-specific N-terminus of
cTnI. This structure also includes the inhibitory peptide of
cTnI (residues 138–148) and the C-terminal residues (resi-
dues 282–285) of cTnT that were not present in Takeda
et al.’s (11) crystal structure (PDB ID 1J1E) and Howarth
et al.’s (21) NMR structure. In previous reports, other
investigators (22–28) and our group (8,29) demonstrated
that mutation of Ser-23 and Ser-24 to aspartic acid (S23D/
S24D) changes the contractile properties of myofibrils
(and trabeculae) and Tn function (in solution) in a manner
consistent with PKA treatment of cTn. Additionally, the
use of these bis-phosphomimics allows investigation of
the specific role of cTnI S23/24 phosphorylation in cardiac
muscle contraction, as titin and myosin-binding protein
C (cMyBP-C) are also phosphorylated by PKA during
b-adrenergic stimulation (30,31). Thus, to mimic phosphor-
ylation and correlate the structure with our functional
results, we performed all-atom/explicit-solvent MD simula-
tions on both wild-type (WT) and cTnI-S23D/S24D cTn
models in triplicate for 150 ns each. Simulation with the
cTnI-S23D/S24D model showed minimal changes in the
site-II Ca2þ-binding loop. In contrast, there were significant
changes in C-I interactions, particularly in the inhibitory-
switch peptide regions. These changes were accompanied
by an N-terminal cTnI interaction with the inhibitory pep-Biophysical Journal 107(7) 1675–1685tide of cTnI that was not present in the WT cTn simulations,
and are consistent with previous predictions based on the
NMR data (7). These data suggest that the phosphomimics
mutant may alter the C-I interaction by directly contacting
the cTnI inhibitory peptide, precipitating an alteration in
switch-peptide interaction with NcTnC.MATERIALS AND METHODS
Initial cTn complex building
The Tn model was built up from the core crystal structure of Takeda et al.
(11) with addition of the N-terminal domain of cTnI, based on the NMR
structure provided by Howarth et al. (21). In this NMR model, the NcTnI
is in close proximity to the NcTnC and interacts with the C-terminus of
cTnI. The crystal structure of the core domain of human cTn in the
Ca2þ-saturated form (Protein Data Bank (PDB) ID 1J1E) (11) was retrieved
from the RCSB PDB. To provide as complete a starting model as possible,
we used the following computational strategy to rebuild crucial residues
missing in the crystal and NMR structures: Only some residues in the
cTnC domain were mutated. All of the mutated residues of cTnC (residues
35, 84, and 115) were modeled back to the WT state. Both the cTnI and
cTnT domains had larger fragments of missing residues. The inhibitory
peptide (residues 137–146) and C-terminus of cTnI (residues 192–210),
and the N-terminus (residues 1–211) and C-terminus (residues 280–288)
of cTnT were missing in the crystal structure. The missing residues of the
cTnI inhibitory peptide and the C-terminus were modeled using Modeler
and Rosetta (32,33). To avoid changing the structure of the N-terminus of
cTnI, one redundant residue (Ala-25) in the NMR structure was also re-
tained in the built-up model. Residues 4, 10, 13, and 19, which were
mutated in the NMR structure, were modeled back to their WT state. Addi-
tionally, the C-terminal residues of cTnTwere modeled using Rosetta; how-
ever, because they are associated with Tm, the residues at the N-terminal
region were not modeled (34). The final model for the MD simulation
was the compacted core structure, including residues cTnC 1–161, cTnI
1–172, and cTnT 236–285 (see Fig. 1 A), and hereafter is referred to as
the WT model.System preparation
To mimic phosphorylation, we constructed a bis-phosphomimics model
by mutating S23/S24 of cTnI to aspartic acid (D). We prepared two
systems of human cTn for simulations: 1), WT Ca2þ-bound cTnC1-161-
cTnI1-172-cTnT236-285 (WT model); and 2), cTnI-S23D/S24D Ca
2þ-bound
cTnC1-161-cTnI1-172-cTnT236-285 (cTnI-S23D/S24D cTn model). cTnI mu-
tations were performed using the Mutate Residue module in VMD (35).
The constructed models were immersed with TIP3P water molecules in a
truncated rectangular box that extended at least 14 A˚ away from any solute
atoms (36). Then, all systems were neutralized and brought to 150 mM
ionic strength by addition of Kþ and Cl ions. The fully solvated systems
contained 112,742 (WT model) or 112,743 (cTnI-S23D/S24D cTn model)
atoms. In subsequent molecular-mechanics minimizations and MD simula-
tions, the CHARMM27 force field was applied to establish the potentials of
the proteins (37).MD simulations
Before conducting the MD simulations, we performed three steps of
minimization using NAMD 2.9 (38): 1), a 10,000-step minimization of
the solvent and ions (with the protein restrained using a force constant
of 500 kcal/mol/A˚2); 2), a 10,000-step minimization of the side chain of
the protein (with the backbone of the protein restrained using a force con-
stant of 500 kcal/mol/A˚2); and 3), a 10,000-step minimization of the entire
FIGURE 1 (A) The initial structures of the WT
cTn complex were built up based on Takeda
et al.’s (11) crystal structure and Howarth et al.’s
(21) NMR structure. The inhibitory-peptide region
(residues 138–147) of cTnI and the C-terminus
(residues 280–285) of cTnT were modeled using
Rosetta. cTnC (1–161) is shown in blue, cTnI (res-
idues 1–172) is in red, and cTnT (residues 236–
285) is in gold. Asterisks indicate the key positions
in cTnI. (B) Close-up of the region around sites
23/24 of cTnI in the cTnI-S23D/S24D cTn model.
The substitutions result in close apposition of
negative charges on D23/D24 of cTnI with E32
and D33 between the A- and B-helices of cTnC.
To see this figure in color, go online.
Troponin Phosphomimic Simulations 1677system without any restraints. Then, we used a short (380 ps) initial MD
simulation with consecutively weaker restraints (10–0.1 kcal/mol/A˚2) on
the protein atoms to gradually heat up the entire system to a temperature
of 300 K. The equilibration was finished by a short (20 ps) NPT simulation
without any restraints.
Next, we performed 150 ns MD simulations in the NPT ensemble at
1 atm pressure and 300 K using NAMD 2.9 (38) and the CHARMM27 force
field (37). For constant pressure control, a default setting was applied. For
constant temperature control, the langevinDamping was set to 1, the
langevinTemp was set to 300 K, and the langevinhydrogen was set to
Off. Particle mesh Ewald (PME) was employed to calculate the long-range
electrostatic interactions, along with a nonbonded interaction cutoff of 12 A˚
(39). The PMETolerance was set to the default value (106), the
PMEInterpOrder was set to 4, and the PMEGridSpacing was set to 1.
Center-of-mass drift due to PME was not removed. Periodic boundary con-
ditions (PBCs) were applied in the simulations, and the wrapWater and
wrapAll were both set to On. The cell origin was defined as (in A˚) 8.6,
45.9, and 25.2; the cellBasisVector1 was defined as (in A˚) 82.4, 0, and 0;
the cellBasisVector2 was defined as (in A˚) 0, 131.3, and 0; and the
cellBasisVector3 was defined as (in A˚) 0, 0, and 110.3. The SHAKE
procedure was applied on the bonds involving hydrogen atoms and the
time step was set to 2.0 fs (40). The geometric tolerance used by SHAKE
was 108 A˚. During the sampling process, the coordinates were saved
every 10 ps.Calcium coordination
To monitor the stability of coordination between site II Ca2þ and its binding
residues of cTnC, we calculated the time evolution of the following dis-
tances for each 150 ns simulation: Ca2þ-Asp-65 OD2, Ca2þ-Asp-67
OD2, Ca2þ-Ser-69 OG, Ca2þ-Thr-71 OG1, Ca2þ-Asp-73 OD2, and Ca2þ-
Glu-76 OE2. All of these atoms correspond to the atoms that coordinate
with the site II Ca2þ ion in the crystal structure (11). Considering that the
coordinating atoms switched occasionally during the course of the simula-
tions, we also recorded additional distances between the following alternate
possible coordinating atoms: Ca2þ-Asp-65 OD1, Ca2þ-Asp-67 OD1, Ca2þ-
Asp-73 OD1, and Ca2þ-Glu-76 OE1. The shorter distance between Ca2þ
and the oxygen atom of residues Asp-65, Asp-67, and Asp-73 was recorded.
Considering that both OE1 and OE2 of Glu-76 coordinate with Ca2þ, we
recorded the distances for both of them. Distances were measured every
10 ps in the two models.Contact analysis
The residue-residue contacts between cTnC and key regions of cTnI (i.e.,
the N-terminus and inhibitory-peptide and switch-peptide regions) were
monitored over the course of the entire simulations. Contacts between
two residues were defined as described previously (15), with a carbon-car-bon distance of%5.4 A˚ and a distance between any other noncarbon atoms
of %4.6 A˚ being considered a contact. Contacts between NcTnC-NcTnI,
between NcTnC and the switch-peptide of cTnI, as well as between
cTnC and the inhibitory-peptide of cTnI were monitored. Intrasubunit inter-
actions between the N-terminus and the inhibitory-peptide region of cTnI
were also recorded. Additionally, contacts between the B- and C-helices
of cTnC, a region that is important for Ca2þ handling (site II Ca2þ binding)
were monitored. For each residue contact pair, the fraction of simulation
time during which these residues were in contact was calculated for both
simulation systems. Residue contact pairs for which that fraction in contact
changed most dramatically upon introduction of the bis-phosphomimic
mutations were identified as hotspot residues.Interhelical angle analysis and solvent-accessible
surface area calculation
The interhelical angles and distances were calculated using interhlx
(K. Yap, University of Toronto). To quantify the exposure of the hydropho-
bic surface in cTnC, which has been shown to be correlated with binding to
the switch peptide of cTnI, 14 hydrophobic residues (Phe-20, Ala-23, Phe-
24, Ile-26, Phe-27, Ile-36, Leu-41, Val-44, Leu-48, Leu-57, Met-60, Phe-77,
Met-80, and Met-81) were selected to calculate the solvent-accessible sur-
face area values via VMD (41) as described previously (15).RESULTS
Global structural behavior
The starting structure for cTn is shown in Fig. 1 A and is
referred to as the WT model. Simulations for cTnI-S23D/
S24D cTn were initiated from the same structure following
the two-residue substitution. Fig. 1 B shows that these sub-
stitutions result in close apposition of negative charges on
position 23/24 of cTnI with E32 and D33 between the A-
and B-helices of cTnC, which may cause repulsive electro-
static interactions.
We compared the dynamics of the two systems from
triplicate 150 ns simulations. The results are demonstrated
by the values of the root mean-square displacement
(RMSD) of the protein backbone atoms (C, CA, and N),
calculated based on the starting structure (see Fig. S1 in
the Supporting Material). The RMSD plot indicates that
the backbone atoms in both complexes were stable after
80 ns. We then calculated the root mean-square fluctuationsBiophysical Journal 107(7) 1675–1685
1678 Cheng et al.(RMSFs) versus the protein residue numbers of each sub-
unit. Fig. 2 A shows the average (5 SD) RMSF of the
cTnC and cTnI subunits for both the WT and cTnI-S23D/
S24D cTn systems in triplicate rounds of MD simulations.
Fluctuations increased for the cTnI-S23D/S24D cTn
model with respect to the WT model. Interestingly,
changes were not distributed equally over the individual
subunits. A large change was observed in NcTnC (cTnC
residues 1–89) and an even more dramatic change was
observed for NcTnI (cTnI residues 1–41). Fig. 2 A high-
lights site I (blue) and site II (the Ca2þ-binding loop;
pink) of cTnC, and the inhibitory-peptide (green) and
switch-peptide regions (orange) of cTnI. These regions
were influenced differently upon introduction of the phos-
phomimic mutations. Site I of cTnC was more flexible
in the cTnI-S23D/S24D cTn model than in the WT model
(the average RMSF for site I increased from 2.4 A˚ to 4.4 A˚
upon phosphomimic mutations). The average RMSF of
cTnC site II also increased slightly upon introduction of
the phosphomimic mutations (2.2 A˚ for WT vs. 3.2 A˚ for
the cTnI-S23D/S24D cTn model). Similarly, the cTnI
switch peptide became more flexible upon introduction of
the phosphomimic mutations (the average RMSF for the
switch peptide increased from 2.8 A˚ to 5.1 A˚). Addition-
ally, the RMSFs of the cTnI inhibitory region and the I-T
arm (cTnI residues 42–137) were virtually unchanged for
the phosphomimic mutants.FIGURE 2 (A) Comparison of average (5 SD) RMSF values of cTnC and cTn
MD simulations. Site I and site II (the Ca2þ-binding loop) of cTnC are highlig
peptide regions of cTnI are highlighted in green and orange, respectively. (B
10 ns during 150 ns MD simulations for both complexes. cTnC is shown in
with dashed circles. To see this figure in color, go online.
Biophysical Journal 107(7) 1675–1685To better visualize how phosphorylation influences sub-
unit interactions in the cTn complex, we overlaid snapshots
taken every 10 ns during the 150 ns MD simulations, as
shown in Fig. 2 B. For clarity, cTnC is shown in blue,
cTnI is in red, and cTnT is in gold. It can be seen in
Fig. 2 B that the N-terminus of cTnI in the cTnI-S23D/
S24D cTn model exhibited greater flexibility with respect
to the WT model. This led to increased fluctuations of the
NcTnC domain. In addition, NcTnI lost interactions with
the C-terminus of cTnI in the cTnI-S23D/S24D cTn model,
whereas some interactions were maintained in the WT
model. As discussed further below, we speculate that this
difference allows NcTnI to become available for interac-
tions with other regions of the cTn complex.Calcium-binding loop
It is difficult to obtain a detailed computational description
of all Ca2þ-related processes, but we measured two param-
eters that are associated with Ca2þ binding in site II: 1), the
time evolution of distances between the bound Ca2þ ion and
its coordinating residues; and 2), the contacts between the
B-helix (cTnC residues 38–48) and C-helix (cTnC residues
54–64) of cTnC. Fig. 3 A shows the site II Ca2þ-binding
loop, as well as the six coordinating residues at the begin-
ning of the simulations. We monitored the distances be-
tween Ca2þ and its six coordinating residues over theI for both the WTand cTnI-S23D/S24D cTn systems in triplicate rounds of
hted in blue and pink, respectively, and the inhibitory-peptide and switch-
) Superposition of snapshots (in cartoon representation) extracted every
blue, cTnI is in red, cTnT is in gold, and all key regions are highlighted
FIGURE 3 (A) Structure of the site II Ca2þ-binding loop at the beginning of the simulation. Six coordinating residues are in stick representation. (B) Dis-
tances between Ca2þ and its coordinating cTnC site II residues (Ser-69 and Thr-71) over the course of each MD simulation for both complexes. The first run
result is shown in black, the second run result is in red, and the third run result is in blue. (C) Coordinating time (percentage) of Ser-69 with Ca2þ during
totally 450 ns MD simulations for the WT and cTnI-S23D/S24D cTn complexes. To see this figure in color, go online.
Troponin Phosphomimic Simulations 1679course of each 150 ns simulation. For four of the residues
(Asp-65, Asp-67, Asp-73, and Glu-76), there was no signif-
icant difference in fluctuation between the cTnI-S23D/S24D
and WT models in any of the simulations (Fig. S2),
and these residues were always coordinated with Ca2þ.
Fig. 3 B shows the distances for the other two coordinating
residues, Ser-69 and Thr-71. Distances fluctuated much
more for these two residues and varied for each run in
both models. The coordinating time for Ser-69 was reduced
equally for both models (Fig. 3 C), which is in agreement
with our previous observation (16).
The contact maps of residue-residue pairs between the
B- and C-helices of cTnC were calculated and are
plotted in Fig. S3 (see legend for color coding). There
was no significant change of contacts between the B- and
C-helices upon introduction of the phosphomimic muta-
tions. Two residues of the C-helix (Leu-57 and Ile-61)
formed strong interactions with the B-helix, indicating
that these residues may be crucial for structural stability
and Ca2þ binding. This result is consistent with our previ-
ous observation that mutation of either residue (L57Q or
I61Q) reduced Ca2þ binding (16). In summary, our ana-
lyses suggest that phosphomimic mutations do not impactthe behavior of coordinating residues or the structure of
the Ca2þ-binding loop.cTnI-S23D/S24D affects interactions of NcTnI with
NcTnC
To identify the C-I contacts that are most affected by phos-
phomimic mutations, we calculated the fraction of contact
time for every residue-residue pair. We first focused on
the binding region between NcTnC (cTnC residues 1–89)
and NcTnI (cTnI residues 1–41). In the WT model
(Fig. 4 A), NcTnI mainly contacts the loop between the A-
and B-helices (LoopA-B) of NcTnC (residues 29–37), as
well as the D-helix (residues 74–83). In contrast, in the
cTnI-S23D/S24D cTn model (Fig. 4 A), NcTnI binds with
NcTnC D-helix residues and the C-helix (residues 54–64),
but not with residues in LoopA-B. This large reduction in
contact time with LoopA-B of cTnC, as well as the greater
contact time with the C-helix of NcTnC, is more clearly
shown in Fig. 4 C, which maps the contact difference be-
tween Fig. 4, A and B.
To further examine the binding interface between NcTnC
and NcTnI, we aligned and compared the structures of theseBiophysical Journal 107(7) 1675–1685
FIGURE 4 (A and B) Average contact maps of residue-residue pairs between NcTnC and NcTnI during 450 ns MD simulations for the (A) WT and (B)
cTnI-S23D/S24D complexes. The blue end of the spectrum (value ¼ 0) reflects no contact between the residue-residue pair, and the red end of the spectrum
(value ¼ 1) represents 100% contact between the residue-residue pair. (C) Difference contact map of residue-residue pairs between NcTnC and NcTnI that
were most affected upon introduction of the phosphomimic mutations. The color green (value¼ 0) reflects no difference between the two systems, the red end
of the spectrum (values> 0) reflects more contacts in the cTnI-S23D/S24D cTn system, and the blue end of the spectrum (values< 0) indicates more contacts
in the WT model. (D) Comparison of interactions between NcTnC and NcTnI during the last 70 ns (from 80 ns to 150 ns) of MD simulations for WT and
cTnI-S23D/S24D complexes. The B-helix (residues 38–48) and C-helix (residues 54–64) of NcTnC (residues 1–89) are highlighted in blue, the other region
of NcTnC is shown in gray, and NcTnI (residues 1–41) is in red. To see this figure in color, go online.
1680 Cheng et al.regions for every 10 ns during the last 70 ns of simulations
(Fig. 4 D). In the WT model, NcTnI was always in close
proximity to the NcTnC region, whereas in the cTnI-
S23D/S24D cTn model, NcTnI flipped over and was in close
proximity to the C-helix of cTnC. As mentioned above, in
the initial WT structure, cTnI sites S23/S24 were close to
the B-helix of cTnC, and residues E32 and D33 were located
at LoopA-B of NcTnC. For the cTnI-S23D/S24D cTn model,
the close apposition of negative charges on D23/D24 of
cTnI with E32/D33 of cTnC may result in repulsive electro-
static interactions that disfavor the WT configuration (see
Fig. 1 B) and thus repel NcTnI. We also calculated the
angles and distances between the B- and C-helices of
NcTnC (Fig. S5), and found no significant change between
the two models.cTnI-S23D/S24D affects cTnI switch peptide-
NcTnC and cTnI inhibitory peptide-cTnC
interactions
We subsequently studied how interactions between the cTnI
switch peptide (cTnI residues 148–164) and NcTnC, as well
as interactions between the cTnI inhibitory peptide (cTnI
residues 138–147) and cTnC, were affected upon introduc-Biophysical Journal 107(7) 1675–1685tion of the S23/S24 phosphomimic mutations into cTnI.
Average contact maps for interactions between the cTnI
switch peptide and NcTnC are shown in Fig. 5, A (WT
model) and B (cTnI-S23D/S24D model). Most of the resi-
due-residue pairs displayed in the figure have an altered per-
centage of contact time with the cTnI-S23D/S24D mutation
model (Fig. 5 C). We also calculated the angles and dis-
tances between the A- and B-helices of cTnC, as well as
the exposure of the hydrophobic patch in cTnC. No signifi-
cant differences were found between the two complexes (the
results are summarized in Figs. S7 and S8). On the other
hand, the average contact maps for interactions between
the cTnI inhibitory peptide and cTnC (Fig. 5,D (WT model)
and E (cTnI-S23D/S24D model)) show that the most pro-
nounced cluster of residues that were affected consists of
residues 55–60, 85–95, and 150–160 of cTnC, as demon-
strated in the difference contact map (Fig. 5 F).cTnI-S23D/S24D leads to the formation of
intrasubunit binding between the N-terminus and
the inhibitory-peptide region of cTnI
In a previous study, Howarth et al. (21) used solution NMR
to determine the structures of the N-terminal extension of
FIGURE 5 (A and B) Average contact maps of residue-residue pairs between NcTnC and cTnI switch peptides for (A) WT and (B) cTnI-S23D/S24D
complexes. (C) Difference contact map of residue-residue pairs between NcTnC and cTnI switch peptides that were most affected upon introduction of
the phosphomimic mutations. (D and E) Average contact maps of residue-residue pairs between cTnC and cTnI inhibitory peptides for the (D) WT and
(E) cTnI-S23D/S24D complexes. (F) Difference contact map of residue-residue pairs between cTnC and cTnI inhibitory peptides that were most affected
upon introduction of the phosphomimic mutations. To see this figure in color, go online.
Troponin Phosphomimic Simulations 1681cTnI for both nonphosphorylated and bis-phosphorylated
species. They applied comparative docking, which was de-
signed to maximize the cardiac N-terminus to interact
with opposite polarity, to determine the low-energy docking
structure. In the low-energy structure, cTnI1-32 resulted in a
weakening interaction with the N-lobe of cTnC and a repo-
sitioning of the cTnI1-32 for favorable interactions with basic
regions of cTnI (most likely the inhibitory region of cTnI).
Specifically, the acidic residues of the N-terminus (Asp-3,
Glu-4, Asp-7, and Glu-11) interacted with residues Arg-
142 and Arg-146 of the inhibitory region (21). To test
the hypothesis that the acidic N0 region of cTnI (residues
2–11) helps regulate myocardial function, Sadayappan
et al. (42) generated cardiac-specific transgenic mice in
which residues 2–11 of cTnI (cTnI (D2–11)) were deleted.
The mouse hearts displayed significantly decreased contrac-
tion and relaxation under basal and b-adrenergic stresscompared with nontransgenic hearts, with a reduction in
maximal Ca2þ-dependent force and maximal Ca2þ-acti-
vated Mg2þ-ATPase activity. However, the Ca2þ sensitivity
of force development and the cTnI-S23/S24 phosphoryla-
tion were not affected. These observations suggest that
residues 2–11 of cTnI, comprising the acidic N0 region, do
not play a direct role in the Ca2þ-induced transition in the
N-lobe of cTnC. Deletion of the conserved acidic N0 region
in cTnI (D2–11) in mice also resulted in a decrease in
myocardial contractility, demonstrating the importance of
the acidic N0 region for regulating myocardial contractility
and mediating the response of the heart to b-adrenergic
stimulation. These results provided further support for the
notion that the acidic N-terminus plays a role in decreasing
cardiac contractility and mediating the response of the heart
to b-adrenergic stimulation by interacting directly with the
inhibitory region of cTnI. Based on this finding (42) andBiophysical Journal 107(7) 1675–1685
1682 Cheng et al.the NMR structural data (21), Solaro et al. (7) predicted that
the phosphorylated N-terminal extension of cTnI can
interact with the inhibitory region of cTnI.
To quantitatively assess whether this interaction can form
upon introduction of the two phosphomimic mutations into
S23/S24 in our MD simulations, we monitored the intrasu-
bunit contacts between the N-terminus and the inhibitory-
peptide region of cTnI for both systems. In the WT model
(Fig. 6 A), no interaction was detected between these two
regions (same finding for all three runs), and this lack of
interaction can be clearly seen in the WT model structure
(Fig. 6 E). Interestingly, in the cTnI-S23D/S24D model,
we found that phosphomimic mutations led to the formationFIGURE 6 (A) Average contact map of residue-residue pairs between the N-te
Contact maps of residue-residue pairs between the N-terminus and inhibitory
simulations. (E and F) Representative binding pattern between the N-terminus
(F) cTnI-S23D/S24D cTn models. To see this figure in color, go online.
Biophysical Journal 107(7) 1675–1685of an intrasubunit interaction between the N-terminus and
the inhibitory-peptide region of cTnI in all three indepen-
dent runs of the MD simulations (Figs. 6, B–D). In our
cTnI-S23D/S24D cTn model, residues 9–14 of the N-termi-
nus could interact with residues 140–142 of the inhibitory
peptide of cTnI (for the detailed binding pattern, see
Fig. 6 F).DISCUSSION
Our goal in this study was to elucidate how the phosphomi-
mic mutant of cTnI (cTnI-S23D/S24D) induces changes in
the cTn structure (via parallel MD simulations) that underlierminus and the inhibitory-peptide region of cTnI for the WT model. (B–D)
-peptide region of cTnI in cTnI-S23D/S24D complexes for three runs of
(red) and the inhibitory-peptide region (blue) of cTnI in the (E) WT and
Troponin Phosphomimic Simulations 1683changes in function reported in the literature (4,5,8,29). To
mimic phosphorylation, we constructed a bis-phosphomi-
mic model (cTnI-S23D/S24D cTn model) by mutating
S23/S24 of cTnI to aspartic acid. The cTnI-S23D/S24D
mutant was previously demonstrated to mimic the PKA
phosphorylation effects on S23/S24 of cTnI (cTnI-pS23/
pS24) both structurally and functionally (22–25). Finley
et al. (22) reported that cTnI (1–80)DD, which has phos-
phorylated serine residues mutated to aspartic acid, served
as a good structural mimetic of the phosphorylated state
and would facilitate future biophysical studies. Subse-
quently, several groups used the cTnI-S23D/S24D mutation
instead of cTnI-pS23/pS24 to study the impact of PKA
phosphorylation on cardiac function because it is a useful
tool for studying the specific effect of PKA phosphorylation
of cTnI (8,25–29) in the absence of cMyBP-C and titin
phosphorylation, which also occurs during b-adrenergic
stimulation (30,31). The major findings of the study pre-
sented here are that the phosphomimic mutations 1), re-
sulted in minimal changes in the site-II Ca2þ binding
loop; 2), significantly altered the C-I interactions, particu-
larly in the inhibitory-switch peptide region; and 3), impor-
tantly, led to the formation of an intrasubunit interaction
between the N-terminus and inhibitory-peptide regions of
cTnI. Taken together, these data suggest that the introduc-
tion of phosphomimic mutations into the N-terminus of
cTnI may alter the C-I interaction by forming a direct con-
tact with the cTnI inhibitory peptide, resulting in an altered
switch-peptide interaction with NcTnC.
The effects of bis-phosphorylation of cTnI on the overall
cTn structure have been studied experimentally. In fluores-
cence studies, Dong et al. (43) found that bis-phosphoryla-
tion resulted in a reduction of the axial ratio of cTnI and
the formation of a more compact structure upon phosphory-
lation. Heller et al. (44) reported that bis-phosphorylation
induced a dramatic bending of the rod-like cTnI at the N-ter-
minal extension that binds with cTnC, resulting in a signif-
icant decrease in the axial ratio of cTnI and the cTn complex
overall. Using surface plasmon resonance, Reiffert et al.
(45) demonstrated that the shape of cTnI changed from an
asymmetrical structure to a more symmetrical one upon
phosphorylation, which is consistent with the bending that
results in a shorter and broader structure. All of these exper-
imental findings suggest that there is an alternative binding
for the bis-phosphorylated cardiac-specific N-terminus. Our
simulations also suggest a bending at the N-terminal exten-
sion of cTnI and a more compact cTn structure upon intro-
duction of the phosphomimic mutations, consistent with
previous biochemical studies (43–45).
Recently, our group studied how PKA phosphorylation of
cTnI modulates the activation and relaxation kinetics of
ventricular myofibrils (8). A major finding of that study
was that PKA phosphorylation of cTnI is responsible for
the reduced duration and increased rate of slow-phase relax-
ation, which speeds overall relaxation, and that this wascorrelated with decreased C-I interaction and binding affin-
ity of Ca2þ to cTnC. We also found that the rate of myofibril
contraction was slowed by PKA phosphorylation at sub-
maximal levels of Ca2þ activation, which is more represen-
tative of the normal heart twitch in vivo. We hypothesized
that changes in the C-I interaction, rather than Ca2þ sensi-
tivity, are responsible for the PKA-modulated thin-filament
activation and relaxation. In support of the idea that cTn
properties can affect relaxation, Narolska et al. (46) reported
that the C-terminus of cTnI increased the duration of slow-
phase relaxation, and our previous study (47) indicated that
a cTnC mutation increased the Ca2þ-binding affinity and
C-I interaction, thereby prolonging the duration of slow-
phase relaxation. In the study presented here, we found
that introducing the two phosphomimic mutations into
S23/S24 had little effect on the site-II Ca2þ-binding loop,
whereas it altered the C-I interactions, especially near the
inhibitory-switch region of cTnI. The most interesting
finding is that the phosphomimic mutants led to the forma-
tion of an intrasubunit interaction between the N-terminus
and the inhibitory-peptide regions of cTnI. Howarth et al.
(21) applied molecular docking designed for maximum in-
teractions of the N-terminal extension with the opposite
polarity region, and provided evidence that the phosphory-
lated N-terminal extension of cTnI can interact with basic
regions of cTnI (most likely the inhibitory region). Sadayap-
pan et al. (42) provided further support for the notion that
the acidic N-terminus plays a role in decreasing cardiac
contractility and mediating the response of the heart to
b-adrenergic stimulation by directly interacting with the
inhibitory region of cTnI. Also, Solaro et al. (7) predicted
the potential interaction between the phosphorylated N-ter-
minal extension of cTnI and the inhibitory-peptide region.
Together, these findings support our finding that the phos-
phomimic mutations led to the intrasubunit interaction
between the N-terminus and inhibitory regions of cTnI.
Burkart et al. (48) reported that phosphorylation of Thr-
144, which is located at the inhibitory region of cTnI, differ-
entially depresses myofilament tension and shortens the
velocity, providing indirect evidence that the intrasubunit
interaction between the N-terminal extension and the inhib-
itory-peptide region may alter cross-bridge kinetics. We
speculate that this intrasubunit interaction may subsequently
weaken interactions between the switch peptide of cTnI and
NcTnC, allowing a stronger interaction between the inhibi-
tory peptide of cTnI and actin (Scheme 1), and thus modu-
late the cross-bridge activity (i.e., increase the slow-phase
relaxation). In the future, it would be interesting to compare
the dynamics of simulated phosphorylated serines with our
current findings regarding phosphomimic mutations.CONCLUSIONS
b-Adrenergic stimulation serves as a primary physiological
mechanism for meeting increased circulatory demands viaBiophysical Journal 107(7) 1675–1685
SCHEME 1 Flow chart of interactions among cTnC, cTnI, and actin in
the presence and absence of Ca2þ, as well as phosphorylation of the S23/
S24 residues of cTnI.
1684 Cheng et al.positive inotropic and lusitropic effects (4). During b-
adrenergic stimulation, cTnI is phosphorylated by PKA at
sites S23/S24, which are located at the N-terminus of
cTnI. This PKA-mediated phosphorylation on sites S23/
S24 of cTnI has been shown to decrease KCa and pCa50,
and weaken the C-I interaction (4). A previous study
demonstrated that PKA phosphorylation of a cardiac
skinned muscle resulted in a decrease in the Ca2þ sensitivity
of muscle contraction, as well as an increased rate of cardiac
muscle relaxation (4,5). In another study (8), we demon-
strated that this phosphorylation resulted in an accelerated
slow-phase relaxation in cardiac myofibril, which sped up
the overall relaxation. However, since the N-terminus of
cTnI has not been resolved in the whole cTn structure, the
molecular-level structural changes that occur in the whole
cTn complex upon cTnI phosphorylation at sites S23/S24
and result in these functional changes have remained
elusive. Our current findings from MD simulations of cTn
containing the N-terminal extension of cTnI provide struc-
tural evidence that supports previous NMR work on partial
protein complexes, as well as previously proposed structure-
function relationships (7,8,29,42). Taken together, these
results show that the combination of solution protein
biochemistry, myofibril mechanics/kinetics measurements,
and computational modeling offers a powerful approach
for determining the molecular mechanisms underlying
how PKA-mediated phosphorylation of myofilament pro-
teins during b-adrenergic stimulation affects the contraction
and relaxation of both normal and diseased cardiac muscle.SUPPORTING MATERIAL
Ninefigures are available at http://www.biophysj.org/biophysj/supplemental/
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